Latest News

Mesoblast (ASX:MSB) is drawing fresh attention after announcing its inaugural R&D Day in New York City on April 8, 2026. At the event, leadership and external experts will outline corporate strategy and pipeline plans. See our latest analysis for Mesoblast. Those R&D Day plans come after a tough stretch for the share price, with a 30 day share price return of a 14.11% decline and a year to date share price return of a 25.27% decline, even though the three year total shareholder return is up...

F5 (FFIV) shares are back in focus after a series of AI centric announcements, including a Skyfire partnership for verified agent traffic and expanded NVIDIA powered inference capabilities within its application delivery and security platform. See our latest analysis for F5. Those AI focused product releases and partnerships with NVIDIA and Skyfire have coincided with building momentum, with a 30 day share price return of 7.29% and a year to date share price return of 13.12%, while the 3 year...

Investors may be wondering whether Constellium’s current share price reflects its real worth, or if the market is overlooking something important in the story. Over the past year the stock has returned 101.7%, with a year-to-date return of 20.0%, a 30-day return of 1.3% and a 7-day return showing a 3.5% decline, which may have investors reassessing both upside potential and risk. Recent coverage around Constellium has focused on its role in the materials sector and how sentiment toward the...

Realty Income (NYSE:O) has entered a $1 billion joint venture with Apollo for a 49% interest in a portfolio of about 500 single-tenant retail properties. The transaction advances Realty Income's private capital initiative by adding a new funding partner while the company keeps long-term management and future call rights. The deal is intended to diversify capital sources beyond traditional markets and support future investment activity in the net lease space. For investors watching NYSE:O,...

NeoGenomics, Inc. recently announced that its PanTracer LBx liquid biopsy test for advanced solid tumors has secured Medicare coverage under the MolDX LCD for plasma-based genomic profiling, enabling covered access to a blood-based panel that analyzes more than 500 genes from a CLIA-certified lab with a seven-day turnaround. This coverage decision not only broadens access to noninvasive genomic testing for Medicare beneficiaries but also highlights the growing clinical role of liquid biopsy...

Intuitive Surgical (ISRG) drew investor attention after recent trading left the stock about 14.6% lower year to date, with the past 3 months and the past month also showing negative total returns. See our latest analysis for Intuitive Surgical. At a latest share price of US$479.93, Intuitive Surgical’s short term momentum has cooled, with a 30 day share price return decline of 2.72% and a year to date share price return decline of 14.6%. The 5 year total shareholder return of 104.37% reflects...

This article examines whether Gartner's current share price reflects fair value, a bargain, or lingering optimism, by breaking down what the market price could be implying about the company. Gartner last closed at US$159.26, with returns of a 0.8% decline over 7 days, 1.9% over 30 days, a 32.8% decline year to date and a 62.0% decline over the past year, which may signal that the market is reassessing its risk and growth profile. Recent coverage has focused on Gartner's role as a key...

CACI International recently completed additional debt financing, issuing US$500 million of unsecured 6.375% Senior Notes due 2033 and arranging US$800 million in incremental term loans, primarily to refinance credit facility borrowings used to acquire ARKA Group L.P. This combination of unsecured notes and secured term loans materially reshapes CACI’s capital structure, tying higher leverage directly to its ARKA acquisition and long-term government technology growth ambitions. We’ll now...

In the past quarter, healthcare-focused fund VR Adviser, LLC disclosed selling 5,845,915 Ocular Therapeutix shares for an estimated US$70.96 million, reducing the position to a smaller slice of its reported assets. This fund rebalancing comes as Ocular Therapeutix faces softer quarterly results, declining revenue, and worsening adjusted operating margins, intensifying scrutiny of its operating model. Next, we’ll examine how these weaker quarterly results and margin pressures may affect...

Independence Realty Trust (IRT) recently came under pressure as real estate investment trusts sold off on renewed inflation worries and rising oil prices, with sentiment further affected by institutional selling and recent price target cuts. See our latest analysis for Independence Realty Trust. At a share price of US$15.54, Independence Realty Trust has experienced a steady share price decline this year, with a year to date share price return of 11.7% and a 1 year total shareholder return of...

In recent days, Riot Platforms has seen heightened attention as analysts reassessed its shift from pure Bitcoin mining toward a vertically integrated data center and power-focused model, while options and technical signals pointed to rising uncertainty around the stock. This combination of a changing business mix and a surge in bearish options activity is drawing fresh scrutiny to how much risk investors are willing to accept in Riot’s evolving story. We'll examine how the surge in bearish...

AGCO share moves and recent performance snapshot AGCO (AGCO) has drawn investor attention after its recent share performance, with the stock down about 1% over the past day, 7% over the past week, and 20% over the past month. See our latest analysis for AGCO. Those short term share price declines sit against a 90 day share price return of 4.86% and a 1 year total shareholder return of 18.63%. This suggests recent momentum has faded even as longer term holders have still seen gains. If AGCO’s...

The California Public Utilities Commission has issued a proposed decision on California Water Service Group (CWT)’s 2024 General Rate Case, outlining multi year rate increases and mechanisms intended to support fixed cost recovery. See our latest analysis for California Water Service Group. The proposed decision appears to have sharpened investor focus, with a 1 day share price return of 2.24% taking California Water Service Group to $44.24. This comes even though the 1 year total shareholder...

Investors may be wondering whether NexGen Energy at around $15.64 is offering value right now, or if most of the easy gains are already behind it. The stock shows mixed recent returns, with a 7.7% decline over the last week and a 1.3% decline over the last month, while still sitting on gains of 11.1% year to date and 116.9% over the past year. Recent coverage around NexGen Energy has focused on its role in the uranium sector and how sentiment toward nuclear energy is shaping investor...

Consolidated Water Co. Ltd. has reported full-year 2025 results, with sales of US$132.07 million versus US$133.97 million a year earlier and net income of US$18.34 million versus US$28.24 million, reflecting softer overall profitability. Despite lower total net income and earnings per share, the company’s earnings per share from continuing operations edged higher, highlighting a relatively stronger performance in its ongoing core businesses. We’ll now examine how the lower full-year net...

Interest in Visa (V) has picked up as the company leans into stablecoin settlement, AI driven fraud tools and new payment partnerships, prompting investors to reassess the stock after recent share price weakness. See our latest analysis for Visa. Despite a busy period that includes new stablecoin settlement volumes, expanded partnerships with firms like Fiserv and Ingenico, and ongoing regulatory headlines, Visa’s 30 day share price return of 6.19% decline and 1 year total shareholder return...

Sea (NYSE:SE) has been under pressure recently, with the share price showing double digit declines over the month and past 3 months, even as the business continues to generate sizeable revenue and earnings. See our latest analysis for Sea. At a share price of $80.98, Sea’s short term momentum has clearly faded. The 30 day share price return is 25.37% and the year to date share price return is 38.41%, while the 1 year total shareholder return of 36.28% and 5 year total shareholder return of...

Earlier this week, Check Point Software Technologies Ltd. launched its Executive Advisory Board and introduced an integration that streams email security telemetry into CrowdStrike Falcon Next-Gen SIEM, enriching investigations by linking inbox, identity and endpoint activity in one workflow. The new board, led by Nadav Zafrir with co-chair Dave DeWalt, together with deeper CrowdStrike integration, underscores Check Point’s push to deepen AI-led security innovation and broaden its role...

Planet Labs PBC has reported its fourth quarter and full-year 2026 results, with sales rising to US$86.82 million for the quarter and US$307.73 million for the year, alongside a wider net loss of US$152.46 million for the quarter and US$246.86 million for the year. The company also outlined revenue guidance of US$87 million to US$91 million for the first quarter of fiscal 2027 and US$415 million to US$440 million for the full year, while deepening its work with NVIDIA to speed up satellite...

NIO (NYSE:NIO) has filed a large shelf registration that would allow the company to issue additional equity securities in the future. The filing gives NIO flexibility to raise capital in one or multiple offerings over time, subject to market conditions and company needs. This move could affect existing shareholders through potential dilution and may reshape views on NIO's funding approach and balance sheet. NIO's new shelf registration arrives at a time when the stock trades around $5.89,...

AMG Critical Materials at a Glance After Recent Share Moves AMG Critical Materials (ENXTAM:AMG) has drawn fresh attention after a recent share price pullback, with the stock down about 11% over the past month but still showing a strong 1 year total return. See our latest analysis for AMG Critical Materials. The recent 11% monthly share price pullback, alongside a 5.6% one day share price decline and 8.9% seven day share price decline, contrasts with a strong 90.96% one year total shareholder...

This article examines whether Genpact, trading at around US$38.31, is a bargain or a value trap by exploring what the current price actually reflects. The stock has been fairly muted in the short term, with returns of 0.4% over 7 days and 1.5% over 30 days. However, the year-to-date return of a 16.6% decline and a 21.2% decline over the past year will be front of mind for many investors. Recent news coverage has focused on Genpact's position as a global professional services and outsourcing...

For readers considering whether Toronto-Dominion Bank at about $128.64 still offers value, or whether the easy gains are already behind it, this article focuses squarely on what the current share price implies. The stock has been relatively steady over the past week with a 0.3% return, while the year-to-date return is around a 0.9% decline, compared with a 56.2% return over 1 year and 91.4% and 94.8% over 3 and 5 years respectively. Recent coverage has focused on how a large North American...

Bavarian Nordic A/S recently reported full-year 2025 results, with sales rising to DKK 6,243.96 million and net income reaching DKK 1,375.38 million, alongside higher earnings per share from continuing operations. A day earlier, the company expanded its partnership with Serum Institute of India to transfer chikungunya vaccine manufacturing and explore further co-development, potentially broadening access in low- and middle-income countries. Next, we’ll assess how the chikungunya tech...